[Clinical evaluation of the antitumor effectiveness of spirobromine].
Borisov
V I
VI
Chernov
V A
VA
Dement'eva
N P
NP
Korobkova
L I
LI
Bogdanova
N V
NV
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D013141:Spiro Compounds / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D013141:Spiro Compounds; C054863:spirobromin
Klinicheskaia otsenka protivoopukholevoĭ éffektivnosti spiroborominma.